San Francisco, CA, February 1, 2026 — TheraNovex, a leader in clinical trial patient recruitment technology, today announced the launch of its revolutionary central campaign management platform. Powered by Agentic AI, the platform enables pharmaceutical sponsors to deploy recruitment campaigns across more than 100 research sites simultaneously. By utilizing autonomous AI agents to manage budgets and optimize performance in real-time, the system consistently outperforms human ad managers by 40% in cost-per-enrollment efficiency.
As clinical trials grow in complexity and geographic scale, traditional site-by-site recruitment methods have become a significant bottleneck. TheraNovex’s new platform addresses these challenges by offering the industry’s first true "set it and forget it" recruitment solution. The Agentic AI architecture allows for sponsor-funded central campaigns to be deployed across an entire site network from a single dashboard, ensuring consistent messaging while maintaining the flexibility for site-specific customization.
Key Features of the Agentic AI Platform
- Autonomous Budget Allocation: AI agents make thousands of micro-decisions daily, shifting spend to the highest-performing sites and channels without human intervention.
- Massive Multi-Site Deployment: Launch standardized recruitment campaigns across 100+ sites with a single click, eliminating months of site-by-site setup.
- Predictive Enrollment Analytics: Advanced forecasting agents adjust budgets proactively based on site capacity, local demographics, and real-time conversion data.
- Cross-Site Intelligence: The system identifies successful strategies at top-performing sites and automatically applies those learnings across the entire network.
- Multi-Channel Optimization: Simultaneous management of bid strategies across Facebook, Google, Instagram, and programmatic display networks.
How It Works
The platform utilizes a sophisticated Agentic AI architecture where multiple specialized agents collaborate to achieve enrollment targets. A Budget Allocation Agent manages the distribution of spend across the network, while a Performance Optimization Agent continuously A/B tests over 1,000 ad variations to identify winning creative combinations. Simultaneously, a Capacity Management Agent monitors each site’s screening bandwidth in real-time. If a site approaches its maximum processing capacity, the AI automatically reduces ad spend for that specific location to prevent lead overflow and wasted resources, reallocating those funds to sites that are falling behind their enrollment targets.
Operational Benefits and Efficiency
The shift from human-managed to AI-managed recruitment campaigns delivers significant measurable improvements to clinical trial timelines and budgets. By operating 24/7 and responding to performance changes within minutes rather than weeks, the TheraNovex platform provides:
- 45% reduction in cost-per-enrollment compared to human-managed campaigns.
- 30% reduction in total recruitment spend through the elimination of wasted leads and inefficient ad placements.
- 50% faster enrollment timelines due to optimized resource allocation and rapid scaling capabilities.
- Unified Reporting: Sponsors gain a single source of truth with real-time dashboards showing enrollment by site, channel, and campaign.
Site-Level Intelligence and Quality Assurance
Beyond budget management, the platform enhances the quality of the recruitment funnel. The AI integrates seamlessly with TheraNovex’s prescreening agents to ensure that only highly qualified patients are delivered to site coordinators. This coordination prevents site staff from being overwhelmed by low-quality leads and ensures that recruitment efforts are perfectly aligned with site availability. This centralized control allows pharmaceutical sponsors and Contract Research Organizations (CROs) to maintain high standards of lead quality and regulatory compliance across diverse geographic regions.
Compliance and Security
TheraNovex maintains a rigorous focus on data integrity and regulatory compliance. The platform includes automated compliance checking for IRB and regulatory requirements, ensuring all ad creative and messaging remain within approved parameters. The system is designed to meet the highest standards of data security, providing sponsors with peace of mind while managing sensitive recruitment data across large-scale, multi-site trials.
About TheraNovex
TheraNovex is a leading clinical trial patient recruitment company dedicated to accelerating the delivery of life-saving therapies. By combining deep clinical expertise with cutting-edge Agentic AI technology, TheraNovex provides pharmaceutical sponsors and CROs with the tools necessary to solve the most complex enrollment challenges. The company’s platform streamlines the recruitment process, reduces costs, and improves the experience for both research sites and patients.
Media Contact:
TheraNovex Team
Email: media@theranovex.com
Website: www.theranovex.com